RecruitingNCT03273049

Mapping Disease Pathways for Biliary Atresia

Coordinating Center- Mapping Disease Pathways for Biliary Atresia

Sponsor

University of Pittsburgh

Enrollment

1,100 participants

Start Date

Jul 21, 2016

Study Type

OBSERVATIONAL

Conditions

Biliary Atresia

Summary

This project will primarily evaluate the developmental/genetic basis of biliary atresia, the most common cause of liver failure at birth, and which accounts of half of all liver transplants performed worldwide in children.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study aims to identify the biological pathways involved in biliary atresia, a rare liver condition in newborns that blocks the bile ducts. By studying tissue and data from patients who have received or are about to receive a liver transplant, researchers hope to find better treatments. You may be eligible if: - You have been diagnosed with biliary atresia - You have received or are scheduled to receive a liver transplant - You are being treated at one of the participating centers (Children's Hospital of Pittsburgh, King's College Hospital, Birmingham Children's Hospital, or Hospital Sirio-Libanes) You may NOT be eligible if: - You are a child in the care of the state - You are in the care of temporary or informal guardians Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.